Common Drinking Habit Triples Risk of Advanced Liver Disease

Occasional binge drinking may significantly increase the risk of developing advanced liver fibrosis, according to a study from the University of Southern California (USC). The research suggests that individuals with underlying metabolic liver disease who engage in episodic heavy drinking face a threefold increase in the risk of this serious condition.

The study found that even a single episode of binge drinking per month was associated with this increased risk. This finding highlights that the pattern of alcohol consumption may be as critical to liver health as the total amount of alcohol consumed over time.

Understanding Advanced Liver Fibrosis

Advanced liver fibrosis occurs during the later stages of chronic liver disease. According to the American Liver Foundation, this condition is characterized by the accumulation of significant scar tissue, which results from chronic, long-term inflammation of the liver.

Medical experts note that consuming large quantities of alcohol within a short window of time is known to trigger inflammation and cause direct damage to the liver.

Study Focus and Methodology

The researchers analyzed six years of data from the U.S. National Health and Nutrition Examination Survey (NHANES), which involved more than 8,000 adults. The primary goal was to determine if the specific pattern of drinking influenced the risk of liver disease differently than the total volume of alcohol intake.

The study specifically focused on individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). This is a form of fatty liver disease linked to metabolic health issues and is currently the most common liver condition in the United States, affecting approximately one-in-three adults.

Large epidemiologic estimates indicate that MASLD affects between 25% and 30% of adults in the U.S.

Shifting Perspectives on Alcohol Consumption

The findings suggest a need to move beyond calculating alcohol risk based solely on weekly averages. Brian P. Lee, MD, a hepatologist and liver transplant specialist with Keck Medicine of USC and the lead investigator of the study, noted the common practice of categorizing patients by their weekly consumption.

Patients often ask how much they can drink. In the liver world, we’re used to thinking about this as an average — for example, we categorize patients based on alcohol consumption per week.

Brian P. Lee, MD, to Fox News Digital

By focusing on episodic heavy drinking, the researchers identified a specific danger for those with MASLD, suggesting that the intermittent nature of binge drinking can be particularly harmful to those with existing metabolic liver vulnerabilities.